Viewing nowRosutagen 20mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Celix Co., Ltd.

MFDS item code 201404015 · Approved 2014.08.28 · Insurance code 646203700
Treatment of dyslipidemia, inhibition of atherosclerosis progression, and reduction of cardiovascular disease risk
This medication is used as an adjunct therapy in patients with hypercholesterolemia and mixed dyslipidemia that are not controlled by diet and exercise alone. It is particularly used in conjunction with other lipid-lowering therapies in patients with homozygous familial hypercholesterolemia, helping to slow the progression of atherosclerosis. Additionally, it is used as an adjunctive dietary therapy for pediatric patients meeting certain criteria with hypercholesterolemia. It is also effective as an adjunct in patients with primary dysbetalipoproteinemia. Furthermore, it helps reduce the risk of stroke, myocardial infarction, and artery revascularization in adult patients with elevated high-sensitivity C-reactive protein and multiple cardiovascular disease risk factors. This medication is effective for reducing the risk of various dyslipidemias and cardiovascular diseases.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine, and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted as a maintenance dose. The maintenance dose is 10 mg once daily, which is adequate for most patients. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 mg once daily. 3. Elderly patients: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering this medicine at a dose of 20 mg to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose is contraindicated in some of these patients.
Age 10 to 17 years: The usual dosage range is 5 mg to 20 mg once daily. There are no clinical data on administering doses higher than 20 mg in pediatric patients. The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years: Safety and efficacy have not been established.
This medication should not be used in certain patients. For example, it should not be given to patients with allergies to its components, patients with active liver disease, patients with muscle disorders, patients with severely impaired kidney function, pregnant or breastfeeding women, and fertile women not using adequate contraception. Additionally, high-dose administration is contraindicated in patients at high risk of muscle-related disorders, which include renal impairment, hypothyroidism, family history of muscle disorders, alcohol abuse, etc. Since this medication contains lactose, it should not be used in patients with lactose intolerance or related genetic disorders. Patients with a history of liver disease or excessive alcohol consumption should repeatedly undergo liver function tests before using this medication. If symptoms such as myalgia, muscle weakness, or myopathy (including myositis) occur, patients should immediately inform their doctor, and blood tests may be necessary to confirm muscle damage. If sudden muscle pain or weakness accompanies fever while taking this medication, the use should be discontinued immediately, and medical consultation sought. This medication may interact with certain drugs; therefore, patients taking other medications should consult their physician or pharmacist. Women who may become pregnant should use appropriate contraception while taking this medication, and if pregnancy is confirmed, they should discontinue use immediately. In the case of overdose, there is no specific antidote, and treatment should be symptomatic; liver function and muscle-related markers should be monitored periodically. This medication can rarely cause severe skin reactions or liver dysfunction; therefore, if symptoms such as rash or jaundice appear, patients should immediately inform healthcare staff. This medication may cause dizziness, so caution is required when driving or operating machinery.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, memory loss, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms syndrome, drug rash with eosinophilia, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disturbances, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal hepatic failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, paresthesia, chest discomfort, decreased appetite, abdominal distension, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to avoid exposure to air or moisture, and it is safe to store it at room temperature between 1 and 30 degrees Celsius. Storing it this way helps maintain the efficacy of the medication.
Pink, round film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Celix Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.